Langenbeck’s Archives of Surgery

, Volume 387, Issue 2, pp 84–89 | Cite as

Efficacy of Ukrain in the treatment of pancreatic cancer

  • Volodimir Zemskov
  • Olga Prokopchuk
  • Yaroslav Susak
  • Sergiy Zemskov
  • Olexander Tkachenko
  • Yuriy Hodysh
  • Wassil Nowicky
Original Article

Abstract

Background. This monocentric study evaluated the effect of Ukrain in the treatment of pancreatic cancer.

Material and methods. Between January 1996 and December 1999 we treated 21 patients with 10 mg Ukrain every second day ×10. The control group received supportive treatment only.

Results. Ukrain treatment was well tolerated. Mean values on pain measure and Karnofsky index were significantly better in the Ukrain group than in controls (P<0.05). One-year survival was 76% in the Ukrain group, compared to 9.5% in the control group. Median survival after treatment with Ukrain was 574 days, compared to 197 days in the control group.

Conclusions. Our data demonstrate that Ukrain improves quality of life in patients suffering from advanced pancreatic cancer and significantly prolongs survival time in these patients.

Pancreatic cancer Ukrain (NSC-631570) Palliative surgery 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag 2002

Authors and Affiliations

  • Volodimir Zemskov
    • 1
  • Olga Prokopchuk
    • 1
  • Yaroslav Susak
    • 1
  • Sergiy Zemskov
    • 1
  • Olexander Tkachenko
    • 1
  • Yuriy Hodysh
    • 2
  • Wassil Nowicky
    • 2
  1. 1.Department of General Surgery, National Medical University, prosp. Holosiivsky, 59B, 03039 Kyiv, UkraineUkraine
  2. 2.Ukrainian Anti-Cancer Institute, Margaretenstrasse 7, 1040 Vienna, AustriaAustria

Personalised recommendations